Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating.
Evogene Schedules First Quarter 2024 Financial Results Release marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Conference call scheduled for 9:00 AM ET
REHOVOT, Israel, Nov. 2, 2023 /PRNewswire/ Evogene Ltd. , a leading computational biology company targeting to revolutionize life-science product.
/PRNewswire/ Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and.
/PRNewswire/ Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery.